Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors.
Anticancer Res. 2008 Mar-Apr;28(2B):1377-81.
Anticancer Res. 2008.
PMID: 18505083
Free article.
Clinical Trial.